top of page
  • Writer's pictureLaurent DECORY

China Oncology: an increasing burden and growth opportunity

With 50 % of global gastric, hepatic, and esophageal cancer cases and high lung cancer incidence, China Oncology market is a unique and challenging opportunity for multinational and local Biopharma.


BlueJet Consulting can help portfolio, launch and go-to-market strategy.




Comments


bottom of page